Skip to main content
Veterinary Medicines

PRIMUN NEWCASTLE HB1 Lyophilisate for suspension for chickens

Authorised
  • Newcastle disease virus, strain B1 Hitchner, Live

Product identification

Medicine name:
PRIMUN NEWCASTLE HB1 Lyophilisate for suspension for chickens
Primun Newcastle HB1 Żywy wirus choroby Newcastle (NDV), szczep lentogeniczny NDV_HB1: 6,0 - 7,0 log10 EID50/1** EID50/1 = 50% dawka zakaźna dla embrionów: miano wirusa powodujące zakażenie u 50%inokulowanych embrionów Liofilizat do sporządzania zawiesiny
Active substance:
  • Newcastle disease virus, strain B1 Hitchner, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain B1 Hitchner, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • (ID2): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID1): 1 Box with 1 Bottle (-) with 1000 Dose (1000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2723
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0272/001
Concerned member states:
  • Italy
  • Poland
  • Portugal
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."